Taysha Gene Therapies, Inc. TSHA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s operating lease liabilities?
- Taysha Gene Therapies, Inc. (TSHA) reported operating lease liabilities of $17.77M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s operating lease liabilities changed year-over-year?
- Taysha Gene Therapies, Inc.'s operating lease liabilities increased by 3.9% year-over-year, from $17.09M to $17.77M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s operating lease liabilities?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating lease liabilities has grown at a -3.8% compound annual growth rate (CAGR), from $20.44M to $18.17M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.